Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: A case-control study

Journal of Laryngology and Otology

Volumn 123, Issue 4, 2009, Pages 444-448

  Asefi, V ^a   Mojtahedi, Z ^b   Khademi, B ^a   Naeimi, S ^b   Ghaderi, A ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Head and neck neoplasms; Interleukin 18; Polymorphism; Squamous cell carcinoma

Indexed keywords

ADENINE; CYTOSINE; DNA; GUANINE; INTERLEUKIN 18;

ADULT; ARTICLE; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE FREQUENCY; GENE SEQUENCE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; AGED; ALLELE; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; HEAD AND NECK TUMOR; MIDDLE AGED;

ADULT; AGED; ALLELES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HEAD AND NECK NEOPLASMS; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 68049088765     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215108003733     Document Type: Article

References (19)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. New Engl J Med 1993;328:184-94
2. Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc 2008;83:489-501
3. Lund VJ, Howard DJ. Head and neck cancer in the young: a prognostic conundrum. J Laryngol Otol 1990; 104:544-8
4. Hopkins J, Cescon DW, Tse D, Bradbury P, Xu W, Ma C et al. Genetic polymorphisms and head and neck cancer outcomes: a review. Cancer Epidemiol Biomarkers Prev 2008;17:490-9
5. Vairaktaris E, Yiannopoulos A, Vylliotis A, Yapijakis C, Derka S, Vassiliou S et al. Strong association of interleukin-6 -174 G>C promoter polymorphism with increased risk of oral cancer. Int J Biol Markers 2006;21: 246-50
6. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001;12:53-72
7. Vidal-Vanaclocha F, Mendoza L, Telleria N, Salado C, Valcárcel M, Gallot N et al. Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression. Cancer Metastasis Rev 2006;25:417-34
8. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001;112:146-52
9. Mojtahedi Z,NaeimiS,Farjadian S,OmraniGR,GhaderiA. Association of IL-18 promoter polymorphisms with predisposition to type 1 diabetes. Diabet Med 2006;23:235-9
10. Bouzgarrou N, Hassen E, Schvoerer E, Stoll-Keller F, Bahri O, Gabbouj S et al. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection. J Med Virol 2008;80:607-14
11. Bushley AW, Ferrell R, McDuffie K, Terada KY, Carney ME, Thompson PJ et al. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol Oncol 2004;95:672-9
12. Liu Y, Lin N, Huang L, Xu Q, Pang G. Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer. DNA Cell Biol 2007;26:613-18
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215
14. Vairaktaris E, Serefoglou ZC, Yapijakis C, Agapi C, Vassiliou S, Nkenke E et al. The interleukin-18 -607A/C polymorphism is not associated with risk for oral cancer. Anticancer Res 2007;27:4011-14
15. Khademi B, Razmkhah M, Erfani N, Gharagozloo M, Ghaderi A. SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer. Pathol Oncol Res 2008;14:45-50
16. Günel N, Coşkun U, Sancak B, Günel U, Hasdemir O, Bozkurt S. Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients. Cancer 2002;95:663-7
17. Jebreel A, Mistry D, Loke D, Dunn G, Hough V, Oliver K et al. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer. J Laryngol Otol 2007;121:246-52
18. Wein RO, Chandra RK, Weber RS. Disorders of head and neck. In: Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Pollock RE. Schwartz's Principles of Surgery, 8th edn. New York: McGraw-Hill, 2005;515-16
19. Harling-Berg CJ, Park TJ, Knopf PM. Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation. J Neuroimmunol 1999; 101:111-27